![]() |
市場調査レポート
商品コード
1504213
スパイロメーターの市場規模、シェア、予測、動向分析:製品別、技術別、用途別、エンドユーザー別-2031年までの世界予測Spirometer Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer ) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
スパイロメーターの市場規模、シェア、予測、動向分析:製品別、技術別、用途別、エンドユーザー別-2031年までの世界予測 |
出版日: 2024年06月01日
発行: Meticulous Research
ページ情報: 英文 290 Pages
納期: 5~7営業日
|
世界のスパイロメーター市場は、2024年から2031年にかけてCAGR 9.2%で2031年までに18億米ドルに達すると予測されます。
本レポートは、広範な2次調査と1次調査、および市場シナリオの詳細な分析を経て、主要な業界促進要因、抑制要因、課題、および機会の分析から構成されています。スパイロメーター市場の成長は、呼吸器疾患の罹患率の上昇、スパイロメーターの技術的進歩、呼吸器疾患に関する意識向上プログラムの増加、在宅ヘルスケアへの嗜好の高まりが原動力となっています。しかし、スパイロメータの高コストと熟練した専門家の不足がこの市場の成長を抑制しています。
さらに、スパイロメータの発展を目指した市場プレイヤー間の提携や協力関係、新興国からの需要の高まりは、この市場で事業を展開するプレイヤーに成長機会をもたらすと期待されています。しかし、代替技術の利用可能性が市場成長の大きな課題となっています。
(注:上位5社のSWOT分析を掲載)
Spirometers Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer [Incentive, Professional, Wireless, Handheld, Stationary, USB]) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User-Global Forecast to 2031
The global spirometers market is projected to reach $1.80 billion by 2031 at a CAGR of 9.2% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the spirometers market is driven by the rising incidence of respiratory diseases, technological advancements in spirometers, increasing awareness programs regarding respiratory diseases, and the growing preference for home healthcare. However, the high cost of spirometers and a shortage of skilled professionals restrain the growth of this market.
Furthermore, partnerships & collaborations between market players aimed at advancing spirometers and the rising demand from emerging economies are expected to generate growth opportunities for the players operating in this market. However, the availability of alternative technologies poses a major challenge to market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global spirometers market are Hill-Rom Holdings, Inc. (U.S.) (a subsidiary of Baxter International Inc. (U.S.)), Schiller Americas Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Koninklijke Philips N.V.(Netherlands), KoKo, LLC (U.S.), Midmark Corporation (U.S.), Geratherm Medical AG (Germany), CHEST M.I., Inc. (Japan), Fukuda Sangyo Co., Ltd. (Japan), ndd Medical Technologies (U.S.), MGC Diagnostics Corporation (U.S.), COSMED srl (Italy), and SIBEL, SAU (Spain).
Among all the products studied in this report, the devices segment is expected to account for the largest share of over 65.2% of the spirometers market. This segment's large market share can be attributed to the increasing approvals of spirometer devices, technological advancements in these devices, and their widespread adoption for monitoring disease progression.
Among all the technologies studied in this report, in 2024, the peak flow measurement segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the ease of use, portability, and cost-effectiveness of peak flow measurement spirometers. These devices are simpler to operate and require minimal setup compared to volume-based devices.
Among all the applications studied in this report, in 2024, the Chronic Obstructive Pulmonary Disease (COPD) segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the high burden of chronic obstructive pulmonary disease (COPD). For instance, according to the National Institutes of Health (NIH), in 2022, 300 million people worldwide were diagnosed with COPD.
Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the rising cases of respiratory conditions such as asthma, COPD, and pulmonary fibrosis, leading to a significant number of patient visits to hospitals and clinics. For instance, according to the Australian Bureau of Statistics, in 2022, 2.8 million individuals were reported to have asthma in Australia.
An in-depth analysis of the geographical scenario of the global spirometers market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 41.6% of the spirometers market. In the region in 2024, the U.S. is expected to account for the largest share of the spirometers market in North America. The large share of the regional market is attributed to the increasing incidence of respiratory diseases leading to higher hospital admissions, the well-established healthcare sector, and the presence of prominent spirometer companies, such as Hill-Rom Holdings, Inc. (U.S.) and Midmark Corporation (U.S.), in this region.
Spirometers Market Assessment-by Product
Note: Other Spirometers include windmill-type spirometers and pneumotachometers.
Spirometers Market Assessment-by Technology
Spirometers Market Assessment-by Application
Note: Other Applications include bronchiectasis, lung cancer, emphysema, and chronic bronchitis.
Spirometers Market Assessment-by End User
Spirometers Market Assessment-by Geography
(Note: SWOT analyses of the top 5 companies will be provided.)